Pancreatic Cancer Research

ResearcherFudan UniversityNo recent work listed

Shanshan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7301-5196; OpenAlex author ID A5100417140. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers

Papers 4

  1. Exosomal lncRNA LINC01268 promotes pancreatic cancer progression via the miR-217-KIF2A-PI3K/AKT axis. Co-author DOI 10.1016/j.gendis.2022.12.018↗
  2. NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer. Co-author DOI 10.1093/carcin/bgac102↗
  3. LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer. Co-author DOI 10.1007/s12672-022-00522-0↗
  4. Identification of prognostic immune-related lncRNAs in pancreatic cancer. Co-author DOI 10.3389/fimmu.2022.1005695↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaomeng He · 4 shared papers, 2022–2023 · strength 0.63
  2. Jin Wang · 4 shared papers, 2022–2023 · strength 0.63
  3. Yan Ma · 3 shared papers, 2022–2023 · strength 0.46
  4. Jianqing Xu · 1 shared paper, 2023 · strength 0.18
  5. Zhihui Bai · 1 shared paper, 2022 · strength 0.16
  6. Di Yang · 1 shared paper, 2022 · strength 0.15
  7. Xiaoyan Zhang · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.